NYSE$CTEV

Claritev Corp · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

Reported strong consecutive quarterly growth and executed its MultiPlan 3.0 growth strategy.

MultiPlan reported strong consecutive quarterly growth and performed better than anticipated amidst the pandemic. The company processed a record $27.8 billion in claims during the third quarter, identifying potential savings of approximately $4.8 billion.

  • Reported positive quarterly growth in both revenues and adjusted EBITDA.
  • Processed a record $27.8 billion in claims, identifying potential savings of approximately $4.8 billion.
  • Completed a comprehensive refinancing program with projected annual interest expense savings of approximately $70 million.
  • Increased the revolving credit facility to $450 million from $100 million to provide additional financial flexibility.

Headline financials

Total Revenue

$224M

Previous: $246M-9.1%
EPS (adj)

-$11.20

Previous: $0.04-26207.2%
Claim Charges Processed

$27.8B

No prior period
Potential Medical Cost Savings

$4.8B

No prior period
Capital Expenditures

$14.5M

No prior period
Free Cash Flow

-$16.1M

No prior period
Net Income

$0.00

Previous: $5.36M-100.0%
Operating Income

$0.00

Previous: $81.1M-100.0%
Gross Profit

$75.7M

Previous: $205M-63.1%
Cash & Equivalents

$0.00

No prior period
Total Assets

$1.11B

No prior period
Stock-Based Comp

$262M

No prior period

Revenue & EPS history

Multiplan · Revenue · Quarterly

$224M

Q3 2020-9.1%vs Q3 2019
Beat estimate in 8 of 9 quarters(89%)
ActualEstimate

Forward guidance

For the fiscal fourth quarter ending December 31, 2020, the Company expects:

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

-6.5%

Avg return

Earnings day

-5.1%

Avg return

5 days after

-3.8%

Avg return

30 days after

36%

9 / 25 earnings

Positive

+20.8%

Q1 2021

Best reaction

-32.8%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-8.8%+7.7%-2.6%
Q4 2025-31.8%-42.0%-31.4%
Q3 2025+11.8%-5.4%-45.2%
Q1 2025+4.2%+7.5%+95.1%
Q4 2024-32.8%-28.1%-24.8%
Q3 2024-6.5%-3.4%-22.6%
Q2 2024-23.9%-10.2%-47.8%
Q1 2024+10.9%-1.5%-36.6%
Q4 2023-0.9%-13.4%-27.6%
Q3 2023-6.5%-9.7%-14.3%
Q2 2023-8.9%-14.0%-17.8%
Q1 2023-5.4%+21.0%+97.6%
Q4 2022-10.2%+10.0%+6.0%
Q3 2022-27.8%-18.3%-31.1%
Q2 2022-12.4%-13.4%-33.1%
Q1 2022+1.0%+18.4%+27.4%
Q4 2021-8.0%-18.9%-14.4%
Q3 2021+0.2%-11.0%-4.3%
Q2 2021-6.2%-10.5%-20.6%
Q1 2021+20.8%+27.0%+45.5%
Q2 2020+0.5%-0.2%+1.9%
Q4 2020-18.6%-20.3%-19.7%
Q3 2020-4.6%+0.7%+20.8%
Q1 2020+0.5%+0.7%+2.3%
Q4 2019+0.5%+0.7%+2.3%
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro